Key Takeaways
- Volume-led beat, supply chain split: India (+16% YoY) and AMET (+15% YoY) powered a 68% EBITDA jump, while ROW volumes fell 9% on logistics disruptions that hit performance surfactants hardest.
- Mix shift drives record realizations: Realization per kg hit an all-time high, surpassing even the supply-led spike of FY22, as specialty care contribution rose and the portfolio churned toward higher-value products.
- Confidence runs ahead of normalization: Management is "extremely confident" momentum sustains even if supply chains normalize, citing a structurally superior portfolio, not transient COVID-era benefits.
- FY27 guidance raised, not just reiterated: Volume growth now expected at the higher end of 6–8%, and EBITDA per metric ton guidance lifted to ₹26,000–₹27,000.
- What to watch next quarter: Whether ROW volumes actually turn positive in H2 as freight rates ease, the pace of new leave-on product commercialization, and any feedstock volatility from West Asia.
Volume Performance: A Tale of Three Regions
- India broad-based surge: 16% YoY volume growth spanned Tier 1, Tier 2, Tier 3, and D2C customers, with reformulation trends turning favorable from April after hurting last year.
- AMET supply-side tailwind: 15% YoY and 16% sequential growth came partly from supply constraints in the local Egypt market benefiting Galaxy, plus growth in markets outside Egypt.
- ROW logistics drag: 9% YoY decline concentrated in performance surfactants, which require responsive, just-in-time delivery and cannot be significantly stocked in warehouses across geographies. Specialty care demand in ROW remained healthy, supporting richer mix.
- Tier 2/3 and D2C recovery: These customer segments returned to healthier growth after a temporary Q1 disruption from elevated input costs.
- Premiumization intact: India consumers continue gravitating toward higher-performance, differentiated products.
Natarajan: "And when we talk to our customers there, I think what constant, this consistent feedback we receive from them is that, you know, that the demand is good and we would like you to ensure that you serve us well."
Specialty Care & Mix: The Structural Story
- Specialty care driving EBITDA: Growth came majorly from mild surfactants and preservatives; the leave-on segment currently represents ~10–15% of the specialty business.
- Record realization per kg: Driven by mix change: specialty portfolio has increased, and within specialty there is churn to higher value-added products, including the Tri-K business in the USA and the rising mild surfactants portfolio.
- Pipeline fructifying: 10 to 12 products launched in the last four quarters; pipelines built over the last two years are converting, with momentum picking up.
- Leave-on ambition: Plan is to reach 25% of total volumes by 2030, anchored by new launches like SunBliss EBD and GalMol CCC introduced at IN Cosmetics Asia in Bangkok.
- New product commercialization lag: These launches typically take 12–18 months to commercialize due to customer testing and stability trials, but initial response is good with projects in the pipeline being built.
- D2C contribution: The D2C segment in India is contributing with specialty ingredients, adding a channel dimension to the mix shift.
Natarajan: "And typically these products will take at least 12 months to 18 months for it to commercialize. It's not going to be something that because people have to test it into the formulation, look at stability and all that. But what is important is that there's a, there's a good response and many of them have started initiating projects in pipeline with us."
Supply Chain & Feedstock Dynamics
- Freight disruption: Rates spiked 3–4x, with port congestion, vessel constraints, and longer transit times affecting shipments from India and Egypt to Latin America, North America, and parts of Europe.
- Petrochemical feedstock tightness: Significant volatility across petrochemical and oleochemical feedstocks driven by West Asia developments, with supply constraints in one key petrochemical raw material.
- Narrow crude-oleochemical delta: The delta between oleochemical and petrochemical feedstock prices has narrowed compared to last year and remains pretty narrow; even with crude coming down, it is not going to significantly change the current mix of petroleum and oleochemical feedstocks in formulations.
- Early moderation signs: Freight rates showing early signs of moderating and supply chain conditions gradually stabilizing, but the situation remains dynamic.
- Customer buying behavior: When demand is robust, customers cannot defer buying because they lose share on the shelf; earlier they took six-month calls, now they may take three-month calls, but they have to buy.
Natarajan: "Even if you have the crude prices coming down, it is not going to significantly change the current mix of petroleum and oleochemical feedstocks that are there in the formulations."
AMET: Demand Resilience & Structural Drivers
- Egypt demand recovery: Local Egypt demand has picked up and consumer sentiments are much better than earlier periods; customers consistently report good demand.
- New consumer equilibrium: Consumers adjusted to higher price listings over time; tier two and tier three customers gaining shares; currency has not been very volatile in the last two years, currency availability is in place, and inflation has been taken care of by income levels going up.
- Tier 2/3 comeback: These customer categories are returning in terms of good demand in Egypt and outside in Africa, Middle East, and Turkey region.
- Management cautious on drill-down: When asked for specific demand drivers (per capita income, climate-related usage), management said they are not able to get any specific point.
Profitability & Guidance
- EBITDA surge: ₹196 crores, up 68% YoY, driven by robust volume growth in India and AMET, richer product mix, increasing specialty care contribution, and disciplined commercial execution.
- EBITDA per metric ton: Improved 56% YoY to ₹26,920, reflecting favorable mix shift and operating leverage.
- FY27 guidance raised: Volume growth expected at the higher end of 6–8%; EBITDA per metric ton guidance enhanced to ₹26,000–₹27,000, supported by improving business mix, continued specialty care momentum, and disciplined commercial execution.
- Long-term EBITDA ambition: Should be upwards of ₹25 per kg; positive impact of actions taken over the last two years has started reflecting this year and will continue to maintain momentum.
- Capex maintained: ₹150 crore for FY27.
- Capacity positioning: India capacity is well placed for increased demand for the coming two to three years from both India and Egypt; projects take 12–15 months for commissioning and will be initiated at the appropriate time to have capacities well ahead of demand growth.
- Specialty capacity utilization: Investments capitalized last year have started getting utilized pretty well, with the specialty ingredients segment contributing to H1 numbers.
Natarajan: "We are coming back after two years of, you know, challenging situation that we were in. So we have started, doing pretty well, and that's what I have been telling you for the last two years, that a lot of actions are being initiated. The external scenario is not favorable, but the moment the external scenario gets sorted out, okay, all our positive impact of the actions that we have been doing for the last two years, we'll start reflecting it has happened this year, and it will continue to maintain that momentum."
Sustainability of Momentum: The Structural Case
- Not a COVID replay: Management is "extremely confident" of sustaining current momentum even if supply chains normalize, citing a structurally superior product portfolio, better mix, improved market presence in Americas and Europe, higher specialty care contribution, increased operating leverage, and D2C penetration built over the last 5 years.
- Differentiated from transient benefits: Unlike COVID-era benefits that evaporated, the current drivers are embedded in the portfolio and channel structure.
- Specialty momentum expected to continue: Management expects to maintain specialty momentum moving forward into the coming months.
- ROW H2 recovery, not full catch-up: With supply chain improving, ROW volumes are expected to grow in H2 FY27 vs the previous year, though not enough to fully catch up on the ~7–8% volume drop.
Natarajan: "No, in fact, we are extremely confident of sustaining this particular momentum. ... the difference between what happened during COVID time and now is that right now our product portfolio is significantly superior. We have a better mix. ... Our operating leverage has gone up significantly. ... So there have been some benefits we have got because of the supply-led disruptions, but we have enough and more that's going to be structurally different from what it was during the COVID period."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Volume growth | Higher end of 6% to 8% | FY27 full year |
| EBITDA per metric ton | ₹26,000–₹27,000 per metric ton | FY27 full year |
| ROW volume growth | Grow in H2 vs previous year, but not fully catch up ~7–8% drop | H2 FY27 |
| Leave-on volume share | Reach 25% of total volumes | By 2030 |
| Capex | ₹150 crore | FY27 |
| New product commercialization | SunBliss EBD, GalMol CCC and other leave-on launches to commercialize | 12–18 months from launch |
| Long-term EBITDA | Upwards of ₹25 per kg | No date; momentum expected to continue |
| Capacity expansion | Initiate investments to stay ahead of demand; projects take 12–15 months to commission | At appropriate time over coming 2–3 years |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Revenue | Not stated |
| EBITDA | ₹196 cr, +68% YoY |
| EBITDA per metric ton | ₹26,920, +56% YoY |
| H1 FY27 EBITDA | ₹448 cr, +78% YoY |
| Full-year volume growth guidance | 6% to 8%, maintained at higher end |
| Full-year EBITDA per metric ton guidance | ₹26,000 to ₹27,000, enhanced from prior guidance |
| India volume growth | ~16% YoY |
| AMET region volume growth | ~15% YoY and 16% QoQ |
| Rest of World volume growth | ~9% decline YoY, logistics-driven |
| Leave-on segment contribution | 10% to 15% of specialty business |
| Leave-on target by 2030 | 25% of total volumes |
| Capacity utilization | ~65% |
| Capex run rate for FY27 | ₹150 cr |
| Interim dividend | ₹18 per share, paid in November |
| Crude oil average price | Above USD 100 per barrel through most of Q2 |
| Oleochemical feedstock (lauryl alcohol) price | ~USD 2,700 per metric ton |
| Freight rates vs pre-West Asia crisis | 3x to 4x historical levels in certain regions |